Medical University of South Carolina researchers reveal a novel binding site for a class of anti-cancer drugs known as E1 inhibitors. The finding could lead to the design of more efficient E1 inhibitors.

Lead Research/Investigator

Shaun Olsen, Ph.D., an assistant professor of Biology and Molecular Biology

Source: EurekAlert!

Pin It on Pinterest